Products

Fmoc-Lys(Pal-Glu-OtBu)-OH

CAS:1491158-62-3

Quantity:

DMF Num:1491158-62-3

Basic information

CAS NO. 1491158-62-3
Purity ≥98%
English name Fmoc-Lys(Pal-Glu-OtBu)-OH
Molecular formula C46H69N3O8
Molecular weight 792.06
Storage conditions 2-8°C

Description

Key Features

Strategic Protection System:

Fmoc group for orthogonal amino protection in SPPS.

OtBu protection on Glu ensures selective deprotection during Liraglutide synthesis.

Palmitoyl (C16) Lipid Tail:Enhances albumin binding, extending peptide half-life by 300% in vivo.

High Purity Profile:Single impurity ≤0.3%, total impurities ≤1.0% (COA with HPLC/NMR/MS data available).

 

Applications

Liraglutide Side Chain Modification:

Critical for introducing the palmitoyl-glutamate moiety at Lys26, enabling albumin binding and 24-hour sustained activity.

Improves receptor binding affinity by 40% compared to unmodified peptides, reducing dosing frequency to daily.

Long-Acting Peptide Development:

Used in GLP-1 agonist analogs for type 2 diabetes/obesity, mimicking natural GLP-1's glucose-lowering effect with enhanced stability.

Lipid tail facilitates self-assembly into micelles, optimizing formulation stability for injectable delivery.

Biomedical Research:

Models for studying lipid-peptide interactions in drug delivery systems.

Supports isotopic labeling (¹³C, ¹⁵N) for NMR-d pharmacokinetic studies.

 

Manufacturing Standards

GMP-Compliant Facility:Produced in ISO 9001:2015 & ISO 14001 certified plant with 100% batch QC, including chiral purity analysis (≥99% ee).

Global Regulatory Support:Provides DMF, CE, REACH, and US FDA documentation for clinical-stage projects.

Stability Testing:Validated for 24 months at 2-8°C, with no degradation under accelerated conditions (40°C, 75% RH for 14 days).

 

Analytical Data

1491158-62-3 HNMR

1491158-62-3 LCMS

 

Services Offered

Structural Modifications:

Alternative fatty acid chains (C14-C18), isotopic labeling (¹³C, ²H) for PK/PD studies.

Custom protection groups (Boc, Cbz) for orthogonal deprotection strategies.

Scalable Production:

100 mg to 5 kg batches, with process validation for GMP-grade materials (≥98.5% purity).

Technical Consultation:

Free synthetic route design by PhD-level chemists, specializing in lipid-peptide conjugation.

 

Company Profile

15+ Years Experience:Specialized in peptide intermediates for global pharma and biotech industries.

R&D Capability:30+ scientists in a 2,000㎡ state-of-the-art laboratory.

Global FootprintServed 500+ clients in 30+ countries, including top 10 global pharma companies.

 

Contact Us

Email:export@pu-kang.com

Phone:+86-137-0808-4407

Address:Zone 1 and 2, 1-3F, Building 3, Chengdu Cross-Strait Science and Technology Industrial Development Park [Jindi Weixin Wenjiang Intelligent Park], Wenjiang District, Chengdu, China.